NCT03764007View on ClinicalTrials.gov

18F-Fluorocholine for the Detection of Parathyroid Adenomas

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

September 21, 2016

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Hyperparathyroidism, Primary
Interventions
DRUG

18F-Fluorocholine

Given intravenously

PROCEDURE

Positron Emission Tomography (PET)

Imaging technique that uses radioactive agents known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

Thomas Hope

OTHER

NCT03764007 - 18F-Fluorocholine for the Detection of Parathyroid Adenomas | Biotech Hunter | Biotech Hunter